Skip to main content
. Author manuscript; available in PMC: 2022 Mar 1.
Published in final edited form as: Adv Drug Deliv Rev. 2021 Jan 9;170:142–199. doi: 10.1016/j.addr.2021.01.005

Fig.13.

Fig.13.

(a) Schematic illustration of the anti-atherosclerosis treatment by preparing HAL@M2 Exo. (b) The inflammation-tropism and anti-inflammation effect of HAL@M2 Exo. (c) The simplified biosynthesis and metabolism pathway of heme induced by HAL. (d) Fluorescence imaging of the aortas excised from mice. (e) Photographs of the excised aortas stained by Oil red O and the corresponding quantitative analyses of plaque areas. (f) Cryosection photographs of the aortic valves stained by Oil red O and the corresponding quantitative analyses of plaque areas. (g) H&E staining images and the necrosis area statistics of aortic valves after different treatments. (h) Western blotting analyses of ABCA-1 and SR-BI. Reproduced with permission from Ref. [353]. Copyright 2020, Wiley-VCH.